0
0
Recent scientific studies have raised significant concerns about the cardiovascular safety of cannabis use, particularly daily or chronic consumption. Emerging evidence from large-scale analyses indicates that individuals who use cannabis regularly face a markedly increased risk of heart attacks, strokes, heart failure, and cardiovascular-related death, even among younger adults free from major preexisting heart conditions. These findings suggest that cannabis, widely perceived as a relatively benign substance, may pose notable cardiovascular risks that warrant heightened public awareness and further clinical scrutiny.
Key Findings from Large-Scale Studies
A retrospective cohort study published in the journal JACC: Advances and presented at the American College of Cardiology’s Annual Scientific Session analyzed data from over 4.6 million U.S. adults aged 50 or younger with no significant cardiovascular comorbidities at baseline. Researchers led by Dr. Ibrahim Kamel found that cannabis users had a sixfold higher risk of myocardial infarction (heart attack), a fourfold increased risk of ischemic stroke, a twofold increased risk of heart failure, and a threefold greater risk of cardiovascular death, heart attack, or stroke compared to non-users over an average follow-up of around three years. These stark risks emerged notwithstanding normal blood pressure, cholesterol, absence of diabetes, and no tobacco use among participants in the study.
Complementing this, a meta-analysis pooling data from 12 prior studies involving over 75 million individuals found that active cannabis users were 1.5 times as likely to suffer a heart attack compared to non-users. While individual studies varied—with some showing no significant difference—the overall combined data underscored a consistent positive association between cannabis use and increased cardiac risk.
More recently, a landmark study published in the Journal of the American Heart Association examined data from more than 430,000 American adults collected between 1999 and 2018 and found that daily cannabis users had a 25% higher risk of developing cardiovascular disease and nearly doubled the risk of fatal heart events compared to non-users. The increased risk was significant specifically among daily users; occasional cannabis use did not show increased cardiovascular mortality.
Expert Opinions and Biological Mechanisms
The biological mechanisms underlying these risks include cannabis-induced elevation of heart rate, blood pressure fluctuations, increased inflammation within blood vessels, and endothelial dysfunction—a critical factor for vascular health. A study led by researchers at UC San Francisco found that chronic cannabis use, whether through smoking or edibles, reduced vascular function by roughly 50% relative to non-users. Notably, smokers also displayed harmful changes in blood serum affecting endothelial cells, which line arteries and veins, potentially promoting atherosclerosis and arterial damage.
Dr. Joseph Wu, professor of cardiovascular medicine at Stanford University, emphasized in a 2022 study that the primary psychoactive cannabinoid THC triggers inflammatory processes and atherosclerosis in blood vessels, which may explain rising heart attack and stroke rates amid increasing marijuana use. Wu’s lab identified a natural molecule, genistein, found in soy and fava beans, that may mitigate these vascular harms without diminishing the beneficial effects of THC on appetite or nausea, opening potential avenues for harm reduction in medical marijuana users.
Public Health Implications
The widespread legalization and growing acceptance of cannabis worldwide intensify the public health imperative to understand and manage its cardiovascular risks. Dr. Abra Jeffers from Massachusetts General Hospital, lead author on the large Journal of the American Heart Association study, urged that both healthcare providers and the public be informed of these risks, noting that cannabis should be “treated like tobacco—not criminalized but discouraged”—due to its impact on heart health.
Cardiologists advocate integrating cannabis use history into clinical cardiovascular risk assessments, akin to smoking history, given the drug’s strong association with adverse heart outcomes. Public health messaging must carefully balance highlighting these risks without sensationalism, particularly as many users may view cannabis as harmless or even beneficial for other reasons.
Limitations and Conflicting Views
While evidence implicates cannabis in cardiovascular risk elevation, some limitations persist. Many studies are observational, meaning causality cannot be fully established, and confounding factors such as lifestyle, underlying mental health conditions, or polydrug use complicate interpretation. Some earlier or smaller-scale research showed mixed or non-significant associations. Additionally, the effects of different cannabis forms (smoking, vaping, edibles) and varying dosages remain under ongoing study.
Researchers also point out a need for long-term prospective data and randomized controlled trials, which remain challenging due to regulatory and ethical issues surrounding cannabis research. However, the existing evidence base is growing robust enough to signal a need for caution and further systematic examination.
Practical Takeaways for Readers
Given the accumulating evidence, individuals—especially those with existing heart disease risk factors or younger adults—should approach cannabis use with caution. Regular or daily cannabis consumption may increase the likelihood of heart attacks, strokes, and fatal cardiovascular events. Healthcare professionals should routinely inquire about cannabis use during patient evaluations and consider it when assessing cardiovascular risk.
For those using marijuana medicinally, consulting healthcare providers about potential cardiovascular effects and exploring possible protective measures, such as dietary supplements like genistein under medical supervision, could be worthwhile. Awareness and education are key to making informed choices about cannabis in the context of overall heart health.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
-
Kamel I, et al. Cannabis Use and Cardiovascular Outcomes in Younger Adults Without Significant Comorbidities. JACC: Advances. 2025; DOI: 10.1016/j.jacc.adv.2025.03.018.
